Is the Challenger Ltd (ASX:CGF) share price in danger?

The Challenger Ltd (ASX:CGF) share price could come under pressure from competition.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The Challenger Ltd (ASX: CGF) share price could come under pressure in the medium-term due to two significant reasons.

Competition

Challenger is the clear market-leader in the annuity space in Australia with an estimated 90% of new annuities heading to the fund manager.

It's one of the key beneficiaries of Australia's ageing population as the core customer group for Challenger is people entering retirement who want a guaranteed source of income from their capital.

However, growth industries, tailwinds and a profitable business model will attract competition. Large competitors are now thinking of entering the fray which could cause problems for Challenger.

According to an article in the AFR, $1.2 trillion global asset management business Standard Life Aberdeen is thinking about offering some sort of retirement income product. It may partner with superannuation funds to offer this.

Allianz and global fixed-income manager PIMCO have announced they will be setting up retirement income products.

Another is Magellan Financial Group Ltd (ASX: MFG), it is also apparently looking at the space.

Rising interest rates

Challenger's success is linked to interest rates more than most other businesses. It has a huge amount of money allocated to fixed income investments which could deteriorate in value if interest rates continue to rise. All of the indicators and comments by the US Fed suggest that rates in the US will indeed continue to rise for the next year or two.

If rates rise in Australia and the US over the medium-term, will annuities be as popular if term deposit rates get back to a more normal level? It's hard to say.

Foolish takeaway

Challenger is trading at 17x FY19's estimated earnings. This isn't expensive compared to the growth that it may achieve in future years, however it has traded at cheaper multiples in the past. I'm holding out for a price that puts it at 15x or 16x FY19's estimated earnings.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited. The Motley Fool Australia owns shares of and has recommended Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A golden egg with dividend cash flying out of it
Growth Shares

Forget Easter eggs, these ASX shares could be your best buys this month

These shares could be top buys after the Easter break.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 amazing ASX growth shares I'd buy and hold for the next decade

These shares could be worth holding tightly to for the long term.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Growth Shares

$5,000 invested in Droneshield shares 4 months ago is already worth…

Investors will be thrilled!

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

1 ASX dividend share and 1 ASX growth stock to buy in April

These ASX shares deliver a one-two punch: income now, growth later.

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »

Scared people on a rollercoaster holding on for dear life, indicating a plummeting share price
Growth Shares

3 reasons to buy this red-hot ASX healthcare stock today

Brokers think the biotech share is gearing up for its next big move.

Read more »

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
Growth Shares

2 ASX stocks that could help turn $10,000 into $1 million

I’d think about adding these ASX shares to your portfolio.

Read more »

Part of male mannequin dressed in casual clothes holding a sale paper shopping bag.
Growth Shares

2 ASX financial stocks that could double – or even triple – in value

If sentiment turns and execution delivers, this could be an opportunity investors won’t want to miss.

Read more »